Trials / Terminated
TerminatedNCT00489658
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
Efficacy and Safety of an Eflornithine + Nifurtimox Combination for Treatment of Late-Stage Human African Trypanosomiasis (HAT) in West Nile, Uganda
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Epicentre · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This case series study follows on a terminated randomised clinical trial in a nearby location of Uganda, in which the combination of eflornithine + nifurtimox showed very promising efficacy and safety. The study's purpose is to evaluate the efficacy and safety of this combination in a larger group of late-stage Human African trypanosomiasis (sleeping sickness) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eflornithine plus Nifurtimox combination therapy |
Timeline
- Start date
- 2002-10-01
- First posted
- 2007-06-21
- Last updated
- 2007-06-21
Locations
1 site across 1 country: Uganda
Source: ClinicalTrials.gov record NCT00489658. Inclusion in this directory is not an endorsement.